Stem cell defects in parthenogenetic peri-implantation embryos

Area of Science:

• Developmental Biology
• Genetics
• Stem Cell Biology

Background:

• Parthenogenetic (maternal chromosome only) mouse embryos exhibit abnormal development, typically failing during the peri-implantation stage.
• The inner cell mass (ICM) of normal embryos maintains undifferentiated stem cells and differentiates into various cell types.

Purpose of the Study:

• To analyze the developmental defects in parthenote embryos using an inner cell mass (ICM) outgrowth assay.
• To investigate the hypothesis that parthenote ICM failure is due to a lack of stem cell proliferation.

Main Methods:

• Utilized an ICM outgrowth assay to mimic peri-implantation development in vitro.
• Analyzed stem cell maintenance and differentiation markers (stage-specific embryonic antigen-1, Rex-1).
• Investigated the effect of mitogenic agents, including insulin-like growth factor-1 receptor (Igf-1r), insulin-like growth factor-2 (Igf-2), and leukemia inhibitory factor (LIF), on parthenote ICM development.

Main Results:

• Parthenote ICMs failed to maintain undifferentiated stem cells and predominantly differentiated into parietal endoderm.
• Supplementation with Igf-1r and Igf-2, or conditioned medium with LIF, temporarily maintained the parthenote ICM population.
• Upon removal of growth factors, parthenote ICM cells still differentiated into parietal endoderm.

Conclusions:

• Parthenote ICMs possess defects leading to both stem cell differentiation and a parietal endoderm fate.
• Growth factors can transiently rescue the stem cell maintenance defect but do not correct the underlying differentiation bias in parthenotes.